As the KIR–HLA-I interactions involve part of the C-terminus of the antigen-binding groove of HLA-I, but may be affected by the respective bound peptide, this suggests a new mechanism for type 1 diabetes pathogenesis. Here, KIR3DL1 is linked to type 1 diabetes mellitus.